Crystal Wang
Oncology Therapeutic Area Medical Lead, Singapore, Malaysia & Brunei Astellas Pharma
Seminars
Thursday 13th November 2025
Panel Discussion: Developing Effective Precision Medicine Strategies for ADCs to Improve Patient Stratification & Enhance Treatment Efficacy
10:00 am
- What are the most critical biomarkers for ADC target selection and patient stratification today?
- How can digital pathology, IHC, and genomics platforms elevate ADC trials?
- What are the best practices for navigating diagnostic regulatory pathways?
- How to design testing networks to ensure equitable diagnostic access
